The cystatin C assay market is set for significant expansion as the global healthcare landscape shifts toward early detection ...

Nov 2024 - PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human ...

Keywords: Nephrology, Glomerular Diseases, Chronic Kidney Disease, Diagnostic Technologies, Personalized Treatment Strategies Important Note: All contributions to this Research Topic must be within ...

Unicycive Therapeutics has positioned itself as an innovator in the CKD treatment space, with its lead product candidate, Oxylanthanum Carbonate (OLC), at the forefront of its development pipeline.

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Credit: Getty Images Drugs for diabetic kidney disease treatment have greatly expanded ... Overcoming Therapeutic Inertia Despite advances in drug therapy, patient outcomes have not improved ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and ...

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, November 11-16 at the Pennsylvania Convention Center in ...